Traumatic brain injury (TBI) is a major cause of morbidity and mortality. Multiple organ dysfunction syndrome (MODS) occurs frequently after TBI and independently worsens outcome. The present study aimed to identify potential admission characteristics associated with post-TBI MODS.
The authors performed a secondary analysis of a recent randomized clinical trial studying the effects of erythropoietin and blood transfusion threshold on neurological recovery after TBI. Admission clinical, demographic, laboratory, and imaging parameters were used in a multivariable Cox regression analysis to identify independent risk factors for MODS following TBI, defined as maximum total Sequential Organ Failure Assessment (SOFA) score > 7 within 10 days of TBI.
Two hundred patients were initially recruited and 166 were included in the final analysis. Respiratory dysfunction was the most common nonneurological organ system dysfunction, occurring in 62% of the patients. International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) probability of poor outcome at admission was significantly associated with MODS following TBI (odds ratio [OR] 8.88, 95% confidence interval [CI] 1.94–42.68, p < 0.05). However, more commonly used measures of TBI severity, such as the Glasgow Coma Scale, Injury Severity Scale, and Marshall classification, were not associated with post-TBI MODS. In addition, initial plasma concentrations of interleukin (IL)–6, IL-8, and IL-10 were significantly associated with the development of MODS (OR 1.47, 95% CI 1.20–1.80, p < 0.001 for IL-6; OR 1.26, 95% CI 1.01–1.58, p = 0.042 for IL-8; OR 1.77, 95% CI 1.24–2.53, p = 0.002 for IL-10) as well as individual organ dysfunction (SOFA component score ≥ 1). Finally, MODS following TBI was significantly associated with mortality (OR 5.95, 95% CI 2.18–19.14, p = 0.001), and SOFA score was significantly associated with poor outcome at 6 months (Glasgow Outcome Scale score < 4) when analyzed as a continuous variable (OR 1.21, 95% CI 1.06–1.40, p = 0.006).
Admission IMPACT probability of poor outcome and initial plasma concentrations of IL-6, IL-8, and IL-10 were associated with MODS following TBI.
ABBREVIATIONSARDS = acute respiratory distress syndrome; CI = confidence interval; CPP = cerebral perfusion pressure; GCS = Glasgow Coma Scale; GOS = Glasgow Outcome Scale; IL = interleukin; IMPACT = International Mission for Prognosis and Analysis of Clinical Trials; ISS = Injury Severity Scale; MODS = multiple organ dysfunction syndrome; OR = odds ratio; SOFA = Sequential Organ Failure Assessment; TBI = traumatic brain injury; TNF = tumor necrosis factor.
AisikuIPYamalJMDoshiPBenoitJSGopinathSGoodmanJC: Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury. Crit Care20:2882016
Chollet-MartinSMontraversPGibertCElbimCDesmontsJMFagonJY: High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun61:4553–45591993
Di BattistaAPRhindSGHutchisonMGHassanSShiuMYInabaK: Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J Neuroinflammation13:402016
GopcevicAMazul-SunkoBMaroutJSekulicAAntoljakNSiranovicM: Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe traumatic brain injury. Tohoku J Exp Med211:387–3932007
KirchhoffCBuhmannSBognerVStegmaierJLeidelBABraunsteinV: Cerebrospinal IL-10 concentration is elevated in non-survivors as compared to survivors after severe traumatic brain injury. Eur J Med Res13:464–4682008
LingsmaHAndriessenTMJCHaitsemaIHornJvan der NaaltJFranschmanG: Prognosis in moderate and severe traumatic brain injury: external validation of the IMPACT models and the role of extracranial injuries. J Trauma Acute Care Surg74:639–6462013
NwachukuELPuccioAMAdeboyeAChangYFKimJOkonkwoDO: Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury. Clin Neurol Neurosurg149:1–52016
RobertsonCSHannayHJYamalJMGopinathSGoodmanJCTilleyBC: Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA312:36–472014
Schneider SoaresFMMenezes de SouzaNLibório SchwarzboldMPaim DiazACosta NunesJHohlA: Interleukin-10 is an independent biomarker of severe traumatic brain injury prognosis. Neuroimmunomodulation19:377–3852012
SteyerbergEWMushkudianiNPerelPButcherILuJMcHughGS: Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med5:e1652008
VincentJLMorenoRTakalaJWillattsSDe MendonçaABruiningH: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med22:707–7101996
Yousefzadeh-ChabokSDehnadi MoghaddamAKazemnejad-LeiliESaneeiZHosseinpourMKouchakinejad-EramsadatiL: The relationship between serum levels of interleukins 6, 8, 10 and clinical outcome in patients with severe traumatic brain injury. Arch Trauma Res4:e183572015